業績一覧
ACHIEVEMENT LIST
-
Homma A, Mikami M, Matsuura K, Onimaru R, Yoshida D, Shinomiya H, Ohkoshi A, Hayashi R, Saito Y, Tachibana H, Shiga K, Ueda T, Uemura H, Nakamura K, Fukuda H; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG): Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (JCOG1212): Results of the efficacy confirmation phase in patients with T4aN0M0: RADPLAT for T4aN0M0 Maxillary Sinus Cancer
Int J Radiat Oncol Biol Phys. 2023 Nov 24:S0360-3016(23)08160-9, 2023
-
Homma A, Ando M, Hanai N, Harada H, Honma Y, Kanda T, Kano S, Kawakita D, Kiyota N, Kizawa Y, Nakagawa M, Ogawa T, Shinomiya H, Shinozaki T, Suzuki M, Tsuji T, Yasuda K, Zenda S, Kodaira T, Kirita T, Nibu K: Summary of Japanese clinical practice guidelines for head and neck cancer – 2022 update edited by the Japan society for head and neck cancer
Auris Nasus Larynx. 51(1):174-188, 2023
-
Kano S, Suzuki T, Yoshida D, Tsushima N, Hamada S, Yasuda K, Uchinami Y, Aoyama H, Homma A: The superselective intra arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is efective for metastatic lymph nodes in head and neck squamous cell carcinoma
Int J Clin Oncol. 28(9): 1121-1128, 2023
-
Fujiwara K, Morita S, Fukuda A, Hoshino K, Nakamaru Y, Homma A: Discrepancies in the caloric testing and video Head Impulse Test results in a case with bilateral lateral semicircular canal malformations.
Auris Nasus Larynx. 50(3): 463-467, 2023
-
Suzuki M, Miyaji K, Matoba K, Abe T, Nakamaru Y, Watanabe R, Suzuki T, Nakazono A, Konno A, Hinder D, Psaltis AJ, Wormald PJ, Homma A: Mental workload during Endoscopic Sinus Surgery is associated with surgeons’ skill level.
Front Med. 10: 1090743, 2023
-
Tsushima N, Kano S, Suzuki T, Hamada S, Homma A: Pretreatment elevated mean corpuscular volume as an indicator for high risk esophageal second primary cancer in patients with head and neck cancer.
Auris Nasus Larynx. 50(3): 423-429, 2023
-
Tsushima N, Kano S, Yasuda K, Suzuki T, Nakamaru Y, Suzuki M, Uchinami Y, Aoyama H, Homma A: Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy.
Int J Clin Oncol. 28(9): 1218-1226, 2023
-
Tsushima N, Kano S, Hatanaka KC, Suzuki T, Hamada S, Idogawa H, Nakamaru Y, Suzuki M, Hatanaka Y, Homma A: Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations
Auris Nasus Larynx. 51(2): 313-319, 2023
-
Kimura S, Suzuki M, Nakamaru Y, Kano S, Watanabe M, Honma A, Nakazono A, Tsushima N, Hatakeyama S, Homma A: TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma.
Rhinology. 61(3): 263-271, 2023
-
Hamada S, Kano S, Murai J, Suzuki T, Tsushima N, Mizumachi T, Suzuki M, Takashima T, Taniyama D, Sakamoto N, Fujioka Y, Ohba Y, Homma A: Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy.
Front Oncol. 19: 1-13, 2023